Alexander Levitzki
Impact in
- Oncology top 0.2%
- Cytokine Signaling Pathways and Interactions
- HER2/EGFR in Cancer Research
- Molecular Biology top 0.2%
- Receptor Mechanisms and Signaling
- Protein Kinase Regulation and GTPase Signaling
- PI3K/AKT/mTOR signaling in cancer
Papers in
-
- Receptor Mechanisms and Signaling 63
- Protein Kinase Regulation and GTPase Signaling 47
- PI3K/AKT/mTOR signaling in cancer 36
- Fungal and yeast genetics research 22
- Oncology 89
- HER2/EGFR in Cancer Research 42
- Cytokine Signaling Pathways and Interactions 24
- Co-authors
- Aviv Gazit (54 shared papers)Chaim Gilon (22 shared papers)Daniel E. Koshland (8 shared papers)David Engelberg (10 shared papers)Nir Osherov (10 shared papers)Moran Benhar (4 shared papers)Michael L. Steer (16 shared papers)Richard Jove (6 shared papers)
- Journals
- Biochemistry (24 papers)Proceedings of the National Academy of Sciences (23 papers)Journal of Biological Chemistry (18 papers)FEBS Letters (16 papers)European Journal of Biochemistry (15 papers)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Alexander Levitzki
346 papers receiving 22.4k citations
Alexander Levitzki's Hit Papers
Peers
Comparison fields: 5 of 154
- Oncology 5.8k
- Molecular Biology 14.8k
- Cell Biology 2.3k
- Hematology 1.5k
- Cancer Research 1.7k
Countries citing papers authored by Alexander Levitzki
This map shows the geographic impact of Alexander Levitzki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Levitzki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Levitzki more than expected).
Fields of papers citing papers by Alexander Levitzki
This network shows the impact of papers produced by Alexander Levitzki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Levitzki. The network helps show where Alexander Levitzki may publish in the future.
Co-authors
The 25 scholars most cited alongside Alexander Levitzki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 349 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tyrosine Kinase Inhibition: An Approach to Drug Development Hit paper breakdown → | 1995 | 1515 |
| 2 | Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells Hit paper breakdown → | 1999 | 1462 |
| 3 | EGF induces tyrosine phosphorylation of phospholipase C-II: A potential mechanism for EGF receptor signaling Hit paper breakdown → | 1989 | 740 |
| 4 | 2001 | 680 | |
| 5 | 1989 | 565 | |
| 6 | Blocking of EGF-Dependent Cell Proliferation by EGF Receptor Kinase Inhibitors Hit paper breakdown → | 1988 | 542 |
| 7 | 2002 | 536 | |
| 8 | Transglutaminase is essential in receptor-mediated endocytosis of α2-macroglobulin and polypeptide hormones Hit paper breakdown → | 1980 | 504 |
| 9 | 1969 | 345 | |
| 10 | 1994 | 311 | |
| 11 | 1978 | 309 | |
| 12 | 1998 | 301 | |
| 13 | 2001 | 281 | |
| 14 | 1992 | 276 | |
| 15 | 1968 | 273 | |
| 16 | 1994 | 255 | |
| 17 | Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation. | 1994 | 254 |
| 18 | 1991 | 248 | |
| 19 | 1971 | 233 | |
| 20 | 1999 | 226 |
About Alexander Levitzki
Alexander Levitzki is a scholar working on Molecular Biology, Oncology, Cell Biology, Hematology and Cellular and Molecular Neuroscience, having authored 349 papers that have together received 24.0k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (63 papers), Protein Kinase Regulation and GTPase Signaling (47 papers), HER2/EGFR in Cancer Research (42 papers), PI3K/AKT/mTOR signaling in cancer (36 papers), Cytokine Signaling Pathways and Interactions (24 papers), Fungal and yeast genetics research (22 papers), Hemoglobin structure and function (20 papers) and Chronic Myeloid Leukemia Treatments (20 papers). The work is most often cited by research in Oncology (5.8k citations), Molecular Biology (14.8k citations), Cell Biology (2.3k citations), Hematology (1.5k citations) and Cancer Research (1.7k citations). Alexander Levitzki has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Aviv Gazit, Chaim Gilon, Daniel E. Koshland, David Engelberg, Nir Osherov, Moran Benhar, Michael L. Steer, Richard Jove, Aviva M. Tolkovsky and Shoshana Klein. Their work appears in journals such as Biochemistry, Proceedings of the National Academy of Sciences, Journal of Biological Chemistry, FEBS Letters and European Journal of Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.